Build a lasting personal brand

MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes

By Advos
MindBio Therapeutics has completed and delivered its first prototypes of Edge AI Intoxication Detection Kiosks, which use AI-powered voice analysis to detect intoxication and fatigue, targeting workplace safety in high-risk industries.

Found this article helpful?

Share it with your network and spread the knowledge!

MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced the completion and delivery of its first prototype Edge AI Intoxication Detection Kiosks, a hardware and software platform that uses AI-powered voice analysis to detect intoxication and fatigue. The kiosks are designed for workplace environments and aim to improve safety across industries where monitoring for drugs, alcohol, and fatigue is critical.

The prototypes will now undergo testing, model validation, and data analysis in collaboration with industry participants, speech experts, and software engineers. MindBio is targeting sectors including mining, aviation, construction, heavy transport, and law enforcement, where regulatory requirements and high-volume testing needs create demand for scalable, noninvasive intoxication and fatigue detection solutions.

The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy using just the human voice. The enterprise platform includes Edge-AI kiosks integrating bespoke hardware and software for detecting drug and alcohol intoxication in a range of enterprise environments. This technology has the potential to transform safety protocols in high-risk industries by providing a rapid, noninvasive alternative to traditional testing methods.

For more details, the full press release is available at https://ibn.fm/wySa8. Updates on MBQIF can be found in the company's newsroom at https://ibn.fm/MBQIF.

Advos

Advos

@advos